Novavax
NVAX
#5751
Rank
C$1.56 B
Marketcap
C$9.65
Share price
0.73%
Change (1 day)
-17.11%
Change (1 year)

Novavax (NVAX) - Total debt

Total debt on the balance sheet as of September 2025 : C$0.35 Billion

According to Novavax's latest financial reports the company's total debt is C$0.35 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novavax - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$0.33 B8.82%
2023-12-31C$0.30 B-59.27%
2022-12-31C$0.74 B28.94%
2021-12-31C$0.57 B-3.04%
2020-12-31C$0.59 B41.94%
2019-12-31C$0.42 B-3.31%
2018-12-31C$0.43 B8.83%
2017-12-31C$0.39 B-6.02%
2016-12-31C$0.42 B77483.14%
2015-12-31C$0.54 M-52.69%
2014-12-31C$1.15 M-42.16%
2013-12-31C$2 M67.1%
2012-12-31C$1.19 M268.12%
2011-12-31C$0.32 M-18.59%
2010-12-31C$0.39 M-21.81%
2009-12-31C$0.51 M-98.16%
2008-12-31C$27.85 M22.73%
2007-12-31C$22.69 M-15.94%
2006-12-31C$26.99 M-24.04%
2005-12-31C$35.54 M-20.37%
2004-12-31C$44.63 M-18.39%
2003-12-31C$54.69 M-16.36%
2002-12-31C$65.39 M19.55%
2001-12-31C$54.7 M82.55%
2000-12-31C$29.96 M20675.29%
1999-12-31C$0.14 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Agenus
AGEN
C$63.89 M-81.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$1.74 B 397.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.92 B 164.04%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C$0.90 B 157.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$45.55 B 12,893.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
C$84.94 B 24,128.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$44.70 B 12,650.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
C$2.09 M-99.40%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$33.31 B 9,401.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
C$3.65 M-98.96%๐Ÿ‡บ๐Ÿ‡ธ USA